Glaucoma is the second most common eye disease to cause blindness due to elevated eye pressure. Eye drops are typically used to administer drugs that lower eye pressure, but this delivery method permits only a small fraction of the active agent to reach the cornea.

This Nanotechnology Engineering team designed an advanced contact lens that uses a hydrogel to contain and control the release of a glaucoma drug. This new form of treatment is revolutionized by real-time monitoring of eye pressure by the integration of a pressure sensor in the contact lens. This will enable optometrists to tailor the drug dose to individual patients based on their eye pressure response to the delivered drug.

Capstone Design Team Members: Shannon Banero, Tina Dekker, Rhiannon Lohr, and Lori Pollit

Follow us on social media!
Twitter: twitter.com/waterlooeng
Facebook: facebook.com/uWaterlooEngineering
Instagram: instagram.com/uwaterlooeng/
LinkedIn: linkedin.com/groups/56527/
Ten Thousand Coffees: tenthousandcoffees.com/hub/waterlooengineering

свернуть